Pfizer sees about $15b in 2021 sales from Covid-19 vaccine

Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German partner BioNTech.
The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.
Comments